Schriesheim, Germany

Felix Rudolphi

This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Bayer Intellectual Property Gmbh, Saltigo Gmbh. Active years: 2011-2016.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.5

ph-index = 1


Location History:

  • Kaiserslautern, DE (2011)
  • Mülheim an der Ruhr, DE (2015)
  • Schriesheim, DE (2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Felix Rudolphi: Innovator in Aryl- and Heteroarylacetic Acid Derivatives

Introduction

Felix Rudolphi is a notable inventor based in Schriesheim, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of aryl- and heteroarylacetic acid derivatives. With a total of 3 patents to his name, Rudolphi's work has implications for various applications in the chemical industry.

Latest Patents

Rudolphi's latest patents focus on a process for preparing aryl- and heteroarylacetic acids and their derivatives. This innovative process involves the reaction of aryl or heteroaryl halides with malonic diesters in the presence of a palladium catalyst, along with one or more bases and optionally a phase transfer catalyst. The method allows for the creation of a wide range of functionalized aryl- and heteroarylacetic acids, including those with sterically demanding substituents.

Career Highlights

Throughout his career, Felix Rudolphi has worked with prominent companies in the chemical sector, including Bayer Intellectual Property GmbH and Saltigo GmbH. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.

Collaborations

Rudolphi has collaborated with several professionals in his field, including Thomas Himmler and Lukas J. Goossen. These collaborations have likely enriched his work and expanded the scope of his research.

Conclusion

Felix Rudolphi stands out as an influential inventor in the realm of chemical processes, particularly in the development of aryl- and heteroarylacetic acid derivatives. His contributions continue to impact the industry and inspire future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…